Adient (NYSE:ADNT – Get Free Report) Director Peter Carlin sold 7,843 shares of the company’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $19.25, for a total value of $150,977.75. Following the sale, the director owned 38,835 shares in the company, valued at $747,573.75. The trade was a 16.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Adient Stock Up 2.0%
Shares of NYSE ADNT traded up $0.40 during trading hours on Friday, hitting $19.97. The company had a trading volume of 619,079 shares, compared to its average volume of 1,016,794. The stock has a market capitalization of $1.54 billion, a P/E ratio of 33.28, a price-to-earnings-growth ratio of 0.39 and a beta of 1.52. The company has a quick ratio of 0.91, a current ratio of 1.10 and a debt-to-equity ratio of 1.18. Adient has a 1-year low of $17.68 and a 1-year high of $27.32. The firm’s 50 day moving average is $19.65 and its 200-day moving average is $21.00.
Adient (NYSE:ADNT – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.08). Adient had a net margin of 0.32% and a return on equity of 7.32%. The firm had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.71 billion. During the same period in the prior year, the business posted $0.45 earnings per share. Adient’s quarterly revenue was up 4.3% compared to the same quarter last year. On average, analysts expect that Adient will post 2.02 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Adient
Analyst Ratings Changes
ADNT has been the topic of several recent analyst reports. Stifel Nicolaus lowered their price objective on shares of Adient from $28.00 to $26.00 and set a “buy” rating on the stock in a research note on Monday, July 20th. Morgan Stanley cut their target price on shares of Adient from $22.00 to $21.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 18th. Citigroup reduced their price target on Adient from $33.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, August 11th. Wells Fargo & Company boosted their price target on Adient from $28.00 to $32.00 and gave the stock an “overweight” rating in a research report on Thursday, June 25th. Finally, BNP Paribas Exane upgraded Adient from a “neutral” rating to an “outperform” rating and set a $26.00 price objective on the stock in a research note on Thursday, July 30th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $26.60.
View Our Latest Stock Report on ADNT
Adient Company Profile
Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.
Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.
See Also
- Five stocks we like better than Adient
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.
